CAR-modified T-cell therapy for cancer: an updated review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR-modified T-cell therapy for cancer: an updated review

Published:2015-06-11 Issue:6 Volume:44 Page:1339-1349
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Haji-Fatahaliha Mostafa¹²³,Hosseini Maryam²³,Akbarian Asiye⁴,Sadreddini Sanam¹²³,Jadidi-Niaragh Farhad⁵,Yousefi Mehdi¹²³

Affiliation:

1. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

2. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

3. Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

4. Department of Microbiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

5. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.3109/21691401.2015.1052465

Reference129 articles.

1. Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy

2. Coupling CD28 Co-Stimulation to Immunoglobulin T-Cell Receptor Molecules: The Dynamics of T-Cell Proliferation and Death

3. Adapting a transforming growth factor β–related tumor protection strategy to enhance antitumor immunity

4. RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells

5. Developing Strategies in the Immunotherapy of Leukemias

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR T‐Cell Therapy for Multiple Myeloma: A Clinical Practice‐Oriented Review;Clinical Pharmacology & Therapeutics;2023-11-04

2. Drug Nanocarriers as a Potential Therapeutic Strategy in Glioblastoma Multiforme;The Neuroscience Journal of Shefaye Khatam;2023-07-01

3. Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials;Frontiers in Immunology;2023-02-03

4. Potential of chimeric antigen receptor ( CAR )‐redirected immune cells in breast cancer therapies: Recent advances;Journal of Cellular and Molecular Medicine;2022-06-28

5. Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model;Pharmaceutical Research;2022-06-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3